1. Roche's risdiplam deal a relief for SMA rivals Biogen and Novartis--for now— AstraZeneca targets summer start for COVID-19 antibody trial — Keros Therapeutics raises $96M in upsized IPO — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Today’s Call

Discussion in 'Kala Pharmaceuticals' started by anonymous, Apr 17, 2019 at 4:52 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    So.....how is everyone feeling about today’s call?

  2. anonymous

    anonymous Guest

    What do YOU think
  3. anonymous

    anonymous Guest

    Come on....tell us how you really feel.

    Spill the beans!
  4. anonymous

    anonymous Guest

    The increase in goals is very aggressive but I think we have a good team in place and smart people at home office.